HiSiaddi is an innovative foreign trade service provider driven by dual engines of technology transformation and foreign trade services. It has established a service system framed as "1+2+3+4=1" and can supply DMSO sourced from multiple well-known original manufacturers.
With over a decade of market experience and technological cooperation with manufacturers, HiSiaddi possesses extensive expertise addressing product compliance challenges. Below is a case of HiSiaddi resolving DMSO compliance issues.
For further inquiries on DMSO product compliance, please contact HiSiaddi customer service.
BioNova Pharma, headquartered in North Rhine-Westphalia, Germany, specializes in the production of sterile injectables and medical transdermal API, with all production lines complying with EMA, cGMP and EP Pharmacopoeia standards. DMSO is used as a co-solvent for injectable-grade API, with an annual purchase of 95 tons of EP pharmaceutical-grade DMSO. The enterprise previously sourced DMSO exclusively from European and American original manufacturers, and selected EP-grade DMSO from a leading domestic pharmaceutical manufacturer for domestic substitution amid international raw material price hikes and extended lead times. After finalizing domestic factory supply and passing sample small trials, four major compliance bottlenecks emerged consecutively. The domestic manufacturer could only provide national standard Chinese COA and lacked capabilities to handle EU import regulations, documentation, labeling and hazardous goods ocean shipping compliance, putting shipments at risk of port detention and return. The client urgently entrusted HiSiaddi Foreign Trade to oversee full-chain compliance rectification.
DMSO (CAS: 67-68-5) requires formal REACH registration and CLP classification filing within the EU. The domestic manufacturer only completed domestic production filings, lacking REACH tonnage registration and EU Only Representative (OR) filing numbers. German Customs pre-judged the material inadmissible for entry per ECHA rules. Unfamiliar with ECHA declaration protocols, the client received exorbitant quotes and 60+ day lead times from independent EU compliance agencies, risking delayed production scheduling.
The manufacturer issued Chinese MSDS and national standard COA. The EU mandates 16-section full English GHS-SDS and EP Pharmacopoeia format batch-specific COA. Original documentation formatting for impurity breakdowns, endotoxin and heavy metal labeling failed EDQM audit standards and was rejected by German pharmaceutical regulatory inspections.
Classified as UN1993 Category 3 flammable liquid, standard plastic pails supplied by the manufacturer lacked UN hazardous goods packaging certification and only bore Chinese text, missing EU GHS hazard pictograms, signal words, CAS numbers and importer information. Port maritime inspections deemed packaging non-compliant and prohibited vessel loading.
The domestic manufacturer held no independent hazardous goods export qualifications, lacking the "Hazardous Goods Packaging Performance Certificate + Usage Identification Certificate" and ocean dangerous goods classification identification document, preventing normal customs clearance and shipment release from domestic warehouses.
1. HiSiaddi collaborated with local European compliance partners to endorse shipments under existing compliant entity OR numbers, complete DMSO batch-specific REACH tonnage notifications and submit product component dossiers to ECHA, securing temporary import filing credentials recognized by German Customs within 3 working days. This eliminated six-figure euro registration costs and multi-month lead times required for independent client registration;
2. Simultaneously assist the client in completing German local importer filing documentation and supplement EU supply chain compliance declarations.
1. Cooperate with authoritative third-party testing institutions to revise full English 16-chapter SDS per EU GHS+EP Pharmacopoeia standards, correcting physical and chemical parameters, impurity limits, toxicological and ecological data to align with CLP regulatory classification requirements;
2. Reformat batch COA to EP Pharmacopoeia standards using raw factory test data, separating heavy metals, trace mercaptans, water content, endotoxin and other mandatory breakdown items required by EU pharmaceutical regulators, affixing bilingual compliance official seals for pre-approval by German pharmaceutical inspectors.
1. Coordinate with the manufacturer to replace pails with UN-certified pharmaceutical-grade HDPE hazardous goods drums and provide full sets of hazardous goods packaging certificates;
2. Uniformly print EU-standard labels listing CAS 67-68-5, UN1993, hazard symbols, EU importer, manufacturer and storage warnings in full English, affixed to all pails to pass maritime packaging inspections.
1. Leverage HiSiaddi’s proprietary hazardous goods foreign trade operation qualifications to apply for domestic hazardous goods classification identification and dual hazardous goods packaging certificates (performance certificate + usage identification);
2. Standardize customs declaration elements with precise HS code, component ratio, application and hazard classification reporting, completing export inspection, maritime DG dangerous goods declaration and port customs clearance in one-stop workflow, mitigating the manufacturer’s lack of export qualifications.
1. Smooth Clearance for First Shipment: After rectification, the first 30-ton container shipped on schedule, passing German Customs and pharmaceutical regulatory inspections without additional screening upon arrival, entering production facilities without incident, with raw material indicators matching European and American imported feedstock;
2. Annual Order Execution: A formal 95-ton annual framework procurement contract was signed for delivery across four stable batches, reducing overall raw material costs by 28% versus original European and American supply pricing;
3. Long-Term Compliance Custodianship: The client entrusted HiSiaddi with ongoing annual EU compliance reviews, batch SDS updates and import filings for all future DMSO and supporting fine solvent shipments, eliminating independent management of complex regulatory formalities;
4. Derivative Cooperation: Word-of-mouth from this compliance service secured additional procurement mandates for pharmaceutical-grade propylene glycol, NMP and other high-purity solvents requiring full compliance support.
High-end overseas pharmaceutical manufacturers prioritize not only product quality but cross-border compliance as the largest barrier to domestic substitution. Production manufacturers excel in manufacturing yet universally lack end-to-end expertise covering international regulations, documentation and customs clearance. HiSiaddi leverages dual domestic and overseas compliance resources to break through dual compliance barriers for domestic export and destination country import in one-stop fashion, forming the core competitive advantage separating it from generic spot goods traders and securing long-term partnerships with high-end end clients.
For further inquiries on DMSO product compliance, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
